on MRM Health
MRM Health Secures €2.6M VLAIO Grant for Inflammatory Disease Research
MRM Health, a biopharmaceutical company located in Ghent, Belgium, has been awarded a €2.6 million research grant from Flanders Innovation and Entrepreneurship (VLAIO). This grant funds a three-year program focusing on developing new therapeutics for immune-mediated inflammatory diseases by exploring the microbiome's role. The program will leverage expertise from renowned Belgian academics to gain insights into bacterial patterns that contribute to these conditions.
The initiative aims to advance safe, oral Live Biotherapeutic Products (LBPs), opening avenues for innovative treatments without immunosuppressive effects. Collaboration with experts like Prof. Jeroen Raes and Prof. Dr. Bram Verstockt will utilize clinical samples to better understand microbe-driven inflammation, potentially revolutionizing treatment strategies for inflammatory diseases.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all MRM Health news